Return on Investment in Endovascular Care: The Case of Endovascular Reperfusion Alberta.
Thanh NX, Jeerakathil T, Stang J, Halabi ML, Mann B, Buck BH, Rempel JL, Goyal M, Demchuk AM, Valaire S, Wasylak T, Hill MD.
Thanh NX, et al. Among authors: stang j.
Can J Neurol Sci. 2022 Sep;49(5):629-635. doi: 10.1017/cjn.2021.189. Epub 2021 Aug 6.
Can J Neurol Sci. 2022.
PMID: 34353400
Probabilities of ERA being cost saving were 39% (31%), 97% (96%), and 94% (91%), for short, medium, and long-term time horizons, respectively. CONCLUSION: The ERA program was cost saving in the medium and long-term time horizons. Results emphasized the importance of …
Probabilities of ERA being cost saving were 39% (31%), 97% (96%), and 94% (91%), for short, medium, and long-term time horizons, resp …